These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21071721)

  • 21. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
    Lindley RI
    Stroke; 2001 Nov; 32(11):2708-9. PubMed ID: 11692040
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 23. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
    Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
    Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early lytic treatment of massive pulmonary embolism.
    Cardiovasc J S Afr; 2002; 13(4):218-9. PubMed ID: 12402933
    [No Abstract]   [Full Text] [Related]  

  • 25. Floating arterial thrombus related stroke treated by intravenous thrombolysis.
    Vanacker P; Cordier M; Janbieh J; Federau C; Michel P
    Cerebrovasc Dis; 2014; 38(2):117-20. PubMed ID: 25278110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A successful case of repeat thrombolysis in prosthetic valve thrombosis.
    Naleem FS; Basavarajaiah S; Aggarwal R
    J Heart Valve Dis; 2010 Jan; 19(1):155-7. PubMed ID: 20329505
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. tPA in daily clinical practice.
    Nighoghossian N
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12733503
    [No Abstract]   [Full Text] [Related]  

  • 29. Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!
    Sandercock P; Lewis S
    Stroke; 2006 Sep; 37(9):2198. PubMed ID: 16888265
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi.
    Vine AK; Maguire PT; Martonyi C; Kincaid MC
    Am J Ophthalmol; 1988 Mar; 105(3):266-70. PubMed ID: 3125746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of fibrinolytic agents during surgical treatment for submacular hemorrhages of various etiology].
    Sosnovskiĭ VV; Sdobnikova SV
    Vestn Oftalmol; 2008; 124(6):47-51. PubMed ID: 19205404
    [No Abstract]   [Full Text] [Related]  

  • 32. Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
    Lindley RI
    Stroke; 2009 Jul; 40(7):2613-4. PubMed ID: 19443793
    [No Abstract]   [Full Text] [Related]  

  • 33. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute recanalization and hyperperfusion in MCA territory due to sole t-PA bolus. A case report.
    Klingner CM; Brodoehl S; Hohenstein C; Witte OW; Günther A
    J Neurol Sci; 2014 Dec; 347(1-2):383-4. PubMed ID: 25284083
    [No Abstract]   [Full Text] [Related]  

  • 35. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
    Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
    J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke--prevention is better than cure.
    Lancet; 2007 Jan; 369(9558):247. PubMed ID: 17258643
    [No Abstract]   [Full Text] [Related]  

  • 37. Dissolution of Urinary Bladder Clots in a Dog with Alteplase.
    Pineda C; Guisado A; Aguilera-Tejero E; Lopez I
    J Vet Intern Med; 2015; 29(6):1627-8. PubMed ID: 26455583
    [No Abstract]   [Full Text] [Related]  

  • 38. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.